A Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer. - sprookjes - yvandenbroek - TriplyDB

A Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer.

A Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer.

http://www.wikidata.org/entity/Q37742623

about

Emerging uses of biomarkers in lung cancer management: molecular mechanisms of resistance.

P2860

Q46071509-4C13163B-AB8F-4E49-9393-72408A4E05C7

P2860

A Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer.

http://www.wikidata.org/entity/Q37742623

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A Neuro-oncologist's Perspecti ...... nt Non-small Cell Lung Cancer.

@en

A Neuro-oncologist's Perspecti ...... nt Non-small Cell Lung Cancer.

@nl

type

label

A Neuro-oncologist's Perspecti ...... nt Non-small Cell Lung Cancer.

@en

A Neuro-oncologist's Perspecti ...... nt Non-small Cell Lung Cancer.

@nl

prefLabel

A Neuro-oncologist's Perspecti ...... nt Non-small Cell Lung Cancer.

@en

A Neuro-oncologist's Perspecti ...... nt Non-small Cell Lung Cancer.

@nl

P1433

Q37742623-D3C3BFBD-2093-4416-89AB-6BDCAAC87DA6

P1476

Q37742623-BE0F1659-D088-4969-B67A-C0CA91317337

P2093

Q37742623-94C17408-BBB6-47D7-AC7E-FA866A51D22B

Q37742623-D25001D8-1B0B-4AD5-9D81-09499E25E835

P275

Q37742623-01580AF4-A783-4693-A8B9-5042BDEE0611

P2860

Q37742623-019C6F72-BC82-49D9-B49B-C3036D752802

Q37742623-0402EE80-A1F6-46E7-9128-576AAC79641D

Q37742623-04F3EC81-7043-4E8E-B80C-ADEC16D2DFC2

Q37742623-0565E798-17A3-4B65-AF5D-E707454FB2E2

Q37742623-09192313-1178-4EA5-9888-E7950A98380A

Q37742623-0A5847AF-9FE3-4E4D-9B5B-4A0721CCD4B5

Q37742623-0E0D7057-8AC4-4905-AAEA-2810479E1245

Q37742623-0EEDC1EC-5DD2-4E9A-AA09-69090248D670

Q37742623-130FB089-87B4-4BFE-A4C7-B22CA4590E9B

Q37742623-136CD16C-46CD-450F-8871-EC621277EE21

P2888

Q37742623-2AF75FFB-EB3F-4D92-8E63-05745F104AF5

P304

Q37742623-63641554-D4A4-4FED-B309-06C5BA2540A7

P31

Q37742623-4947A6EB-D354-4951-8C6C-373833C20589

Q37742623-C56944C8-6F2C-415D-BCCB-F25112C45AE9

P356

Q37742623-38FDD886-5D5B-4419-89F0-DF4B36BB20A8

P433

Q37742623-91F2C0EE-5E9D-4542-B3A4-67636C7B3044

P478

Q37742623-9A4B8EE2-C24C-48D8-8407-C7B26982765A

P5008

Q37742623-86E34B70-CE4C-4245-A016-B0942BE8D907

P577

Q37742623-CD741088-4466-401E-94C7-D6B2163C1DC2

P698

Q37742623-1D3C3F35-CF44-4D5C-A769-61E48523C65F

P921

Q37742623-3AB06E33-EB4F-4DB7-BEE3-06B50F6A9DE4

Q37742623-4FC1E247-D420-4E67-986F-7CDDF30808D7

Q37742623-B814608C-6A2A-40A6-8679-A01F013E0080

Q37742623-BA4BDBEE-64B0-4048-B7F0-786A6CC40512

Q37742623-D309856E-03FF-42C6-912B-D52432E46566

Q37742623-D87099DA-FB9E-4527-8391-F5CC5CF0E26A

Q37742623-D9AC773B-F71B-4069-82EA-59A9EAF6687D

Q37742623-E14B0FF4-9F60-443D-A69E-B4BD7E6ECA0E

Q37742623-F1FAE09E-FD9B-4A87-9FA8-AC46C48FB5AC

P932

Q37742623-8A5E20CF-94E1-4659-9EEC-32F76C758AAA

P356

S11864-017-0466-0

P1433

Current Treatment Options in Oncology

P1476

A Neuro-oncologist's Perspecti ...... nt Non-small Cell Lung Cancer.

@en

P2093

Seema Nagpal

http://www.w3.org/2001/XMLSchema#string

Tresa McGranahan

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Checkpoint inhibitors in lung cancer: latest developments and clinical potential

Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis.

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.

Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastases

P2888

s11864-017-0466-0

P304

22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11864-017-0466-0

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28391420

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

genetic variation

non-small-cell lung carcinoma

membrane proteins

P932

5385200

http://www.w3.org/2001/XMLSchema#string